Gaudia, Cheryl M.
HRN: 27-69-67 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2025
CEFUROXIME 500MG (TAB)
09/19/2025
09/25/2025
PO
500mg
BID
NSVD With RMLE
Checking Initial Appropriateness
09/20/2025
CEFUROXIME 500MG (TAB)
09/20/2025
09/25/2025
PO
500mg
BID
NSVD With RMLE
Waiting Final Action